201 related articles for article (PubMed ID: 19257814)
1. Loss of Cbl-b increases osteoclast bone-resorbing activity and induces osteopenia.
Nakajima A; Sanjay A; Chiusaroli R; Adapala NS; Neff L; Itzsteink C; Horne WC; Baron R
J Bone Miner Res; 2009 Jul; 24(7):1162-72. PubMed ID: 19257814
[TBL] [Abstract][Full Text] [Related]
2. Loss of Cbl-PI3K interaction enhances osteoclast survival due to p21-Ras mediated PI3K activation independent of Cbl-b.
Adapala NS; Barbe MF; Tsygankov AY; Lorenzo JA; Sanjay A
J Cell Biochem; 2014 Jul; 115(7):1277-89. PubMed ID: 24470255
[TBL] [Abstract][Full Text] [Related]
3. The loss of Cbl-phosphatidylinositol 3-kinase interaction perturbs RANKL-mediated signaling, inhibiting bone resorption and promoting osteoclast survival.
Adapala NS; Barbe MF; Langdon WY; Nakamura MC; Tsygankov AY; Sanjay A
J Biol Chem; 2010 Nov; 285(47):36745-58. PubMed ID: 20851882
[TBL] [Abstract][Full Text] [Related]
4. Cafestol has a weaker inhibitory effect on osteoclastogenesis than kahweol and promotes osteoblast differentiation.
Fukuma Y; Sakai E; Nishishita K; Okamoto K; Tsukuba T
Biofactors; 2015; 41(4):222-31. PubMed ID: 26154488
[TBL] [Abstract][Full Text] [Related]
5. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype.
Rea SL; Walsh JP; Ward L; Yip K; Ward BK; Kent GN; Steer JH; Xu J; Ratajczak T
J Bone Miner Res; 2006 Jul; 21(7):1136-45. PubMed ID: 16813535
[TBL] [Abstract][Full Text] [Related]
6. Bergapten suppresses RANKL-induced osteoclastogenesis and ovariectomy-induced osteoporosis via suppression of NF-κB and JNK signaling pathways.
Chen G; Xu Q; Dai M; Liu X
Biochem Biophys Res Commun; 2019 Feb; 509(2):329-334. PubMed ID: 30579598
[TBL] [Abstract][Full Text] [Related]
7. c-Cbl and Cbl-b act redundantly to protect osteoclasts from apoptosis and to displace HDAC6 from beta-tubulin, stabilizing microtubules and podosomes.
Purev E; Neff L; Horne WC; Baron R
Mol Biol Cell; 2009 Sep; 20(18):4021-30. PubMed ID: 19641021
[TBL] [Abstract][Full Text] [Related]
8. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
[TBL] [Abstract][Full Text] [Related]
9. c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption.
Tanaka S; Amling M; Neff L; Peyman A; Uhlmann E; Levy JB; Baron R
Nature; 1996 Oct; 383(6600):528-31. PubMed ID: 8849724
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the classical NF-kappaB pathway prevents osteoclast bone-resorbing activity.
Soysa NS; Alles N; Shimokawa H; Jimi E; Aoki K; Ohya K
J Bone Miner Metab; 2009; 27(2):131-9. PubMed ID: 19172225
[TBL] [Abstract][Full Text] [Related]
11. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
12. (2S)-2'-Methoxykurarinone inhibits osteoclastogenesis and bone resorption through down-regulation of RANKL signaling.
Kim JY; Kim JY; Kim JJ; Oh J; Kim YC; Lee MS
Biol Pharm Bull; 2014; 37(2):255-61. PubMed ID: 24492722
[TBL] [Abstract][Full Text] [Related]
13. Loss of Cbl-PI3K interaction in mice prevents significant bone loss following ovariectomy.
Adapala NS; Holland D; Scanlon V; Barbe MF; Langdon WY; Tsygankov AY; Lorenzo JA; Sanjay A
Bone; 2014 Oct; 67():1-9. PubMed ID: 24994594
[TBL] [Abstract][Full Text] [Related]
14. The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: increased resorption and osteopenia in me(v)/me(v) mutant mice.
Aoki K; Didomenico E; Sims NA; Mukhopadhyay K; Neff L; Houghton A; Amling M; Levy JB; Horne WC; Baron R
Bone; 1999 Sep; 25(3):261-7. PubMed ID: 10495129
[TBL] [Abstract][Full Text] [Related]
15. Ampelopsis brevipedunculata extract prevents bone loss by inhibiting osteoclastogenesis in vitro and in vivo.
Kim JY; Park SH; Oh HM; Kwak SC; Baek JM; Lee MS; Rho MC; Oh J
Molecules; 2014 Nov; 19(11):18465-78. PubMed ID: 25397737
[TBL] [Abstract][Full Text] [Related]
16. Total saponin from Anemone flaccida Fr. Schmidt abrogates osteoclast differentiation and bone resorption via the inhibition of RANKL-induced NF-κB, JNK and p38 MAPKs activation.
Kong X; Wu W; Yang Y; Wan H; Li X; Zhong M; Zhao H; Su X; Jia S; Ju D; Lin N
J Transl Med; 2015 Mar; 13():91. PubMed ID: 25889035
[TBL] [Abstract][Full Text] [Related]
17. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
Zhang Z; Jimi E; Bothwell AL
J Immunol; 2003 Oct; 171(7):3620-6. PubMed ID: 14500659
[TBL] [Abstract][Full Text] [Related]
18. Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling.
Rahman MM; Bhattacharya A; Fernandes G
J Lipid Res; 2006 Aug; 47(8):1739-48. PubMed ID: 16702601
[TBL] [Abstract][Full Text] [Related]
19. A novel small molecule, NecroX-7, inhibits osteoclast differentiation by suppressing NF-κB activity and c-Fos expression.
Kim HJ; Yoon KA; Lee MK; Kim SH; Lee IK; Kim SY
Life Sci; 2012 Nov; 91(19-20):928-34. PubMed ID: 23000100
[TBL] [Abstract][Full Text] [Related]
20. Piperine alleviates osteoclast formation through the p38/c-Fos/NFATc1 signaling axis.
Deepak V; Kruger MC; Joubert A; Coetzee M
Biofactors; 2015; 41(6):403-13. PubMed ID: 26627060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
